Choroidal melanoma, a rare form of eye cancer, arises from the pigment-producing cells in the choroid layer of the eye. Despite its rarity, it poses a significant threat to vision and can metastasize, primarily to the liver, if left untreated. Research in this area focuses on early detection methods, such as high-resolution imaging techniques and genetic profiling, to identify at-risk individuals and provide timely interventions. Treatment options include radiation therapy, surgery, and in some cases, enucleation (removal of the eye). The development of targeted therapies and immunotherapies holds promise for improving outcomes and reducing the risk of metastasis in choroidal melanoma patients. Ongoing efforts in cancer research aim to elucidate the molecular mechanisms driving this disease and discover novel therapeutic targets to enhance patient care.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States